Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Licensed provider reviews your profile before prescribing, then your Rx goes straight to the pharmacy
There is no downtime and you can resume normal daily activities right away post-treatment
Scientists behind the supplement believe it offers consumers a safer alternative to traditional GLP-1 drugs, but without concerns over side effects
Early effects may appear within a few weeks, while more noticeable fat loss often occurs after 2 to 3 months
The studies we are seeing presented at this years annual meeting show great promise to fuel new solutions and treatment options for patients across the globe living with type 2 diabetes and obesity. Drug Treatment for Obesity Effectively Reduces Body Weight and Blood Pressure HRS9531 is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, offering a treatment option for individuals with overweight or obesity, as well as type 2 diabetes
US$ 24.83
US$ 20.55
US$ 20.06
